What drugs does SYNTHON PHARMS make?

SYNTHON PHARMS has 9 FDA-approved drugs.

What therapeutic areas does SYNTHON PHARMS focus on?

SYNTHON PHARMS focuses primarily on Neurology and Cardiovascular and 1 other therapeutic areas.

Data updated: Mar 10, 2026

SYNTHON PHARMS

NeurologyCardiovascularMetabolic

Generics

SYNTHON PHARMS is a generic drug manufacturer focused on Neurology, Cardiovascular, Metabolic. Key products include ZOLPIDEM TARTRATE.

2001

Since

Drugs

Trials

102

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

AMLODIPINE BESYLATE 2026-02-17

Manufacturing (CMC)

GLATIRAMER ACETATE 2026-02-11

AMLODIPINE BESYLATE 2026-01-26

Manufacturing (CMC)

AMLODIPINE BESYLATE 2026-01-22

GLATIRAMER ACETATE 2025-12-31

RISPERIDONE 2025-11-04

Labeling

LETROZOLE 2025-10-24

Labeling

ANASTROZOLE 2025-10-24

Labeling

ANASTROZOLE 2025-10-24

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 33%

1 drugs

Cardiovascular 33%

1 drugs

Metabolic 33%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Novo Nordisk big-pharma

Metabolic, Cardiovascular, Neurology

UPJOHN big-pharma

Neurology, Cardiovascular, Metabolic

AZURITY specialty

Cardiovascular, Neurology, Metabolic

Merck big-pharma

Cardiovascular, Metabolic

Johnson & Johnson big-pharma

Cardiovascular, Metabolic

SYNTHON PHARMS

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (9)

Active (4)

Discontinued (5)

Company Info